Mostrar el registro sencillo del ítem
dc.contributor.author
Zhou, Bin
dc.contributor.author
Carrillo Larco, Rodrigo M.
dc.contributor.author
Danaei, Goodarz
dc.contributor.author
Riley, Leanne M.
dc.contributor.author
Paciorek, Christopher J.
dc.contributor.author
Stevens, Gretchen A.
dc.contributor.author
Gregg, Edward W.
dc.contributor.author
Bennett, James E.
dc.contributor.author
Solomon, Bethlehem
dc.contributor.author
Singleton, Rosie K.
dc.contributor.author
Sophiea, Marisa K.
dc.contributor.author
Iurilli, Maria LC
dc.contributor.author
Lhoste, Victor PF
dc.contributor.author
Cowan, Melanie J.
dc.contributor.author
Savin, Stefan
dc.contributor.author
Woodward, Mark
dc.contributor.author
Balanova, Yulia
dc.contributor.author
Cifkova, Renata
dc.contributor.author
Damasceno, Albertino
dc.contributor.author
Elliott, Paul
dc.contributor.author
Farzadfar, Farshad
dc.contributor.author
He, Jiang
dc.contributor.author
Ikeda, Nayu
dc.contributor.author
Kengne, Andre P.
dc.contributor.author
Khang, Young Ho
dc.contributor.author
Chang Kim, Hyeon
dc.contributor.author
Laxmaiah, Avula
dc.contributor.author
Lin, Hsien Ho
dc.contributor.author
Margozzini Maira, Paula
dc.contributor.author
Rubinstein, Adolfo Luis
dc.date.available
2023-09-22T11:46:04Z
dc.date.issued
2021-09
dc.identifier.citation
Zhou, Bin; Carrillo Larco, Rodrigo M.; Danaei, Goodarz; Riley, Leanne M.; Paciorek, Christopher J.; et al.; Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 a pooled analysis of 1201 population-representative studies with 104 million participants; Elsevier Science Inc.; Lancet; 398; 10304; 9-2021; 957-980
dc.identifier.issn
0140-6736
dc.identifier.uri
http://hdl.handle.net/11336/212637
dc.description.abstract
BACKGROUND: Hypertension can be detected at the primary health-care level and low-cost treatments can effectively control hypertension. We aimed to measure the prevalence of hypertension and progress in its detection, treatment, and control from 1990 to 2019 for 200 countries and territories. METHODS: We used data from 1990 to 2019 on people aged 30-79 years from population-representative studies with measurement of blood pressure and data on blood pressure treatment. We defined hypertension as having systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or taking medication for hypertension. We applied a Bayesian hierarchical model to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control). The model allowed for trends over time to be non-linear and to vary by age. FINDINGS: The number of people aged 30-79 years with hypertension doubled from 1990 to 2019, from 331 (95% credible interval 306-359) million women and 317 (292-344) million men in 1990 to 626 (584-668) million women and 652 (604-698) million men in 2019, despite stable global age-standardised prevalence. In 2019, age-standardised hypertension prevalence was lowest in Canada and Peru for both men and women; in Taiwan, South Korea, Japan, and some countries in western Europe including Switzerland, Spain, and the UK for women; and in several low-income and middle-income countries such as Eritrea, Bangladesh, Ethiopia, and Solomon Islands for men. Hypertension prevalence surpassed 50% for women in two countries and men in nine countries, in central and eastern Europe, central Asia, Oceania, and Latin America. Globally, 59% (55-62) of women and 49% (46-52) of men with hypertension reported a previous diagnosis of hypertension in 2019, and 47% (43-51) of women and 38% (35-41) of men were treated. Control rates among people with hypertension in 2019 were 23% (20-27) for women and 18% (16-21) for men. In 2019, treatment and control rates were highest in South Korea, Canada, and Iceland (treatment >70%; control >50%), followed by the USA, Costa Rica, Germany, Portugal, and Taiwan. Treatment rates were less than 25% for women and less than 20% for men in Nepal, Indonesia, and some countries in sub-Saharan Africa and Oceania. Control rates were below 10% for women and men in these countries and for men in some countries in north Africa, central and south Asia, and eastern Europe. Treatment and control rates have improved in most countries since 1990, but we found little change in most countries in sub-Saharan Africa and Oceania. Improvements were largest in high-income countries, central Europe, and some upper-middle-income and recently high-income countries including Costa Rica, Taiwan, Kazakhstan, South Africa, Brazil, Chile, Turkey, and Iran. INTERPRETATION: Improvements in the detection, treatment, and control of hypertension have varied substantially across countries, with some middle-income countries now outperforming most high-income nations. The dual approach of reducing hypertension prevalence through primary prevention and enhancing its treatment and control is achievable not only in high-income countries but also in low-income and middle-income settings. FUNDING: WHO.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier Science Inc.
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/
dc.subject
Global Health
dc.subject
Antihypertensive Agents
dc.subject
Hypertension
dc.subject
Prevalence
dc.subject.classification
Otras Ciencias de la Salud
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019 a pooled analysis of 1201 population-representative studies with 104 million participants
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2023-09-18T13:38:59Z
dc.journal.volume
398
dc.journal.number
10304
dc.journal.pagination
957-980
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Zhou, Bin. Imperial College London; Reino Unido
dc.description.fil
Fil: Carrillo Larco, Rodrigo M.. Imperial College London; Reino Unido
dc.description.fil
Fil: Danaei, Goodarz. Harvard Medical School; Estados Unidos
dc.description.fil
Fil: Riley, Leanne M.. WHO; Suiza
dc.description.fil
Fil: Paciorek, Christopher J.. University of California; Estados Unidos
dc.description.fil
Fil: Stevens, Gretchen A.. Imperial College London; Reino Unido
dc.description.fil
Fil: Gregg, Edward W.. Imperial College London; Reino Unido
dc.description.fil
Fil: Bennett, James E.. Imperial College London; Reino Unido
dc.description.fil
Fil: Solomon, Bethlehem. Imperial College London; Reino Unido
dc.description.fil
Fil: Singleton, Rosie K.. Imperial College London; Reino Unido
dc.description.fil
Fil: Sophiea, Marisa K.. Imperial College London; Reino Unido
dc.description.fil
Fil: Iurilli, Maria LC. Imperial College London; Reino Unido
dc.description.fil
Fil: Lhoste, Victor PF. Imperial College London; Reino Unido
dc.description.fil
Fil: Cowan, Melanie J.. WHO; Suiza
dc.description.fil
Fil: Savin, Stefan. WHO; Suiza
dc.description.fil
Fil: Woodward, Mark. Imperial College London; Reino Unido. University of New South Wales; Australia
dc.description.fil
Fil: Balanova, Yulia. National Medical Research Centre for Therapy and Preventive Medicine; Rusia
dc.description.fil
Fil: Cifkova, Renata. Karlova Univerzita; República Checa
dc.description.fil
Fil: Damasceno, Albertino. Eduardo Mondlane University; Mozambique
dc.description.fil
Fil: Elliott, Paul. Imperial College London; Reino Unido
dc.description.fil
Fil: Farzadfar, Farshad. Non-Communicable Diseases Research Center; Irán
dc.description.fil
Fil: He, Jiang. University of Tulane; Estados Unidos
dc.description.fil
Fil: Ikeda, Nayu. National Institutes of Biomedical Innovation, Health and Nutrition; Japón
dc.description.fil
Fil: Kengne, Andre P.. South African Medical Research Council; Sudáfrica
dc.description.fil
Fil: Khang, Young Ho. Seoul National University College of Medicine; Corea del Sur
dc.description.fil
Fil: Chang Kim, Hyeon. Yonsei University College of Medicine; Corea del Sur
dc.description.fil
Fil: Laxmaiah, Avula. National Institute of Nutrition; India
dc.description.fil
Fil: Lin, Hsien Ho. National Taiwan University; China
dc.description.fil
Fil: Margozzini Maira, Paula. Pontificia Universidad Católica de Chile; Chile
dc.description.fil
Fil: Rubinstein, Adolfo Luis. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
dc.journal.title
Lancet
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1016/S0140-6736(21)01330-1
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0140673621013301
Archivos asociados